Cargando…
An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases
A 53-year-old man with advanced lung adenocarcinoma harboring epidermal growth factor receptor (EGFR) exon 19 deletion received erlotinib. After 12 months of disease control with erlotinib monotherapy, leptomeningeal metastases (LM) occurred. A cerebrospinal fluid examination demonstrated a pre-exis...
Autores principales: | Tsuchiya, Kazuo, Karayama, Masato, Yasui, Hideki, Hozumi, Hironao, Suzuki, Yuzo, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Nakamura, Yutaro, Inui, Naoki, Suda, Takafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306543/ https://www.ncbi.nlm.nih.gov/pubmed/30101917 http://dx.doi.org/10.2169/internalmedicine.1062-18 |
Ejemplares similares
-
Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine
por: Akiyama, Norimichi, et al.
Publicado: (2017) -
Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray
por: Karayama, Masato, et al.
Publicado: (2021) -
Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease
por: Koda, Keigo, et al.
Publicado: (2021) -
Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy
por: Karayama, Masato, et al.
Publicado: (2021) -
Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis
por: Suzuki, Yuzo, et al.
Publicado: (2018)